Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunomodulation of innate and adaptive immune responses refers to the regulation of both the immediate, non-specific (innate) and the delayed, specific (adaptive) arms of the immune system. Innate immunity relies on pattern recognition receptors (PRRs) such as Toll-like receptors, RIG-I-like receptors, Nod-like receptors, and C-type lectin receptors that detect pathogens or cellular damage and initiate signaling cascades involving cytokines (e.g., type I interferons, interleukins), thereby stimulating or shaping subsequent adaptive immune responses such as T cell and B cell activation[1][2][3][4][5][7]. Adaptive immunity is characterized by antigen-specific recognition and immune memory, orchestrated by lymphocytes, chiefly T cells and B cells[7]. Multiple molecular mechanisms and cell types are involved in the cross-talk between these systems, including antigen-presenting cells, cytokines, immune checkpoint proteins, and regulatory T cells, highlighting the integrated, complex nature of immune regulation and the importance of specific molecular targets within this broader process[1][2][3][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunomodulation of innate and adaptive immune responses.